Topics
October 2020 | Meeting Minute
Subretinal Gene Therapy
This new technology is filled with promise.
Christina Y. Weng, MD, MBA, and Jonathan F. Russell, MD, PhD
Intraocular Tumors: A Look Into the Future
The Taylor Smith and Victor Curtin Lecture was given by Carol L. Shields, MD, at this year’s meeting.
Carol L. Shields, MD, and Jonathan F. Russell, MD, PhD
Aspen Retinal Detachment Society Meeting Coverage: Ocular Oncology and Retinal Gene Therapy
Timothy G. Murray, MD, MBA
October 14, 2026
European Trial Finds PRIMA Retinal Implant Demonstrates Sustained Vision Improvement at 3 Years in GA
Cosmetic Products Linked to More than 42,000 Eye Injuries Over 20 Years, Study Finds
October 12, 2026
ANI Pharmaceuticals Reports Sustained 24-Month Efficacy of Iluvien in Phase 4 SYNCHRONICITY Trial
Merck’s Remigromig Meets Primary Endpoint in Phase 2b/3 BRUNELLO Trial for DME
October 2026 Insert
Editorially Independent Content, Supported With Advertising From Asetllas
Editorially independent supported by Abbvie and Regenxbio
Free Print Subscription
Email Newsletter
Conference Calendar